NOVARTIS-CENA713D2320

Study Sponsor: Novartis

Study Title

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Medicine or Vaccine (generic name)

rivastigmine

Sponsor Identification Number

CENA713D2320

Trial Registry Identification Number(#'s)

NCT00099242

Medical Condition

Alzheimer's Disease

Phase

Phase 3

Link to study details on the Novartis Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

April 2017